Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Dermatology
•
Drug Eruptions
How do you approach monitoring in DRESS or DiHS patients?
Which tests do you order and when do you re-order tests?
Related Questions
After corticosteroids, what second line agent do you select to treat drug induced hypersensitivity syndrome (also known as DRESS syndrome)?
How often do you pursue malignant transformation screening In patients with lymphomatoid papulosis or pityriasis lichenoides?
What laboratory workup do you perform in patients with symptoms consistent with erythromelalgia?
What is your treatment approach to non-uremic calciphylaxis? Which treatment modalities do you combine?
How would you approach management of an elderly patient with known mantle cell lymphoma and new diagnosis of cryoglobulinemic vasculitis with mild skin involvement, fatigue, arthralgias but no other major organ involvement?
What is the role of combination antimicrobial, antiviral, and immunomodulatory therapies in managing recurrent erythema multiforme with suspected infectious triggers?
What treatment combination approach would you recommend for mucous membrane pemphigoid?
Do you pursue a cardiac evaluation in all patients with an excised cutaneous myxoma?
Would you switch azathioprine to a different immunosuppressant if a controlled patient with SLE develops melanoma and/or non-melanoma skin cancer?
How soon after excising a keloid do you inject kenalog?
